Camber Pharmaceuticals, Inc. Recalls

Camber Pharmaceuticals Recalls Ketorolac Injection Over Glass Particles

Camber Pharmaceuticals, Inc. recalled Ketorolac Tromethamine Injection on October 1, 2025. The recall affects a specific lot due to the presence of glass particles. This recall pertains to the 60 mg/2 mL single-dose vials distributed nationwide.